DekaBank Deutsche Girozentrale Raises Stock Position in Maximus, Inc. (NYSE:MMS)

DekaBank Deutsche Girozentrale lifted its position in Maximus, Inc. (NYSE:MMSFree Report) by 501.4% during the fourth quarter, Holdings Channel reports. The institutional investor owned 42,100 shares of the health services provider’s stock after buying an additional 35,100 shares during the quarter. DekaBank Deutsche Girozentrale’s holdings in Maximus were worth $3,511,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently modified their holdings of the company. DAVENPORT & Co LLC purchased a new position in shares of Maximus in the 4th quarter worth approximately $1,157,000. Legato Capital Management LLC grew its position in shares of Maximus by 134.1% in the 4th quarter. Legato Capital Management LLC now owns 23,521 shares of the health services provider’s stock worth $1,972,000 after buying an additional 13,474 shares during the last quarter. Graham Capital Management L.P. purchased a new position in shares of Maximus in the 3rd quarter worth approximately $2,709,000. SG Capital Management LLC purchased a new position in shares of Maximus in the 3rd quarter worth approximately $5,951,000. Finally, SG Americas Securities LLC purchased a new position in shares of Maximus in the 3rd quarter worth approximately $2,262,000. Hedge funds and other institutional investors own 97.21% of the company’s stock.

Maximus Stock Down 0.4 %

NYSE:MMS opened at $79.94 on Friday. The company’s 50 day moving average is $82.58 and its two-hundred day moving average is $80.90. The company has a market cap of $4.88 billion, a PE ratio of 26.47 and a beta of 0.72. The company has a current ratio of 1.69, a quick ratio of 1.69 and a debt-to-equity ratio of 0.71. Maximus, Inc. has a twelve month low of $72.39 and a twelve month high of $89.69.

Maximus (NYSE:MMSGet Free Report) last released its quarterly earnings data on Wednesday, February 7th. The health services provider reported $1.34 EPS for the quarter, beating the consensus estimate of $1.28 by $0.06. The business had revenue of $1.33 billion for the quarter, compared to the consensus estimate of $1.29 billion. Maximus had a net margin of 3.73% and a return on equity of 15.68%. The business’s revenue for the quarter was up 6.2% on a year-over-year basis. During the same period in the prior year, the firm earned $0.94 EPS. Analysts anticipate that Maximus, Inc. will post 5.41 EPS for the current year.

Maximus Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, May 31st. Stockholders of record on Wednesday, May 15th will be issued a $0.30 dividend. This represents a $1.20 annualized dividend and a dividend yield of 1.50%. The ex-dividend date is Tuesday, May 14th. Maximus’s dividend payout ratio (DPR) is currently 39.74%.

Insider Activity

In other news, CFO David Mutryn sold 8,000 shares of the company’s stock in a transaction on Friday, February 16th. The shares were sold at an average price of $83.95, for a total value of $671,600.00. Following the sale, the chief financial officer now directly owns 5,124 shares of the company’s stock, valued at approximately $430,159.80. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 1.40% of the company’s stock.

Analyst Ratings Changes

Several analysts have weighed in on MMS shares. Raymond James downgraded shares of Maximus from an “outperform” rating to a “market perform” rating in a research report on Wednesday, January 3rd. StockNews.com raised shares of Maximus from a “hold” rating to a “buy” rating in a research report on Thursday, February 8th.

Read Our Latest Analysis on Maximus

Maximus Company Profile

(Free Report)

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.

Further Reading

Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus, Inc. (NYSE:MMSFree Report).

Institutional Ownership by Quarter for Maximus (NYSE:MMS)

Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.